Cenexi to manufacture OSE's COVID-19 vaccine

By The Science Advisory Board staff writers

June 30, 2021 -- Cenexi signed a deal agreeing to manufacture clinical batches of CoVepiT, OSE Immunotherapeutics' COVID-19 vaccine candidate, which will be used in the product's development phases.

Under the deal, Cenexi will make and process the peptides, produce the sterile emulsion, and package clinical batches of the vaccine that is being used in the ongoing phase I clinical trial. The next-generation candidate is a multitarget, multivariant vaccine. The manufacturing will occur at Cenexi's site in Hérouville-Saint-Clair in Normandy, France. The site has a filling capacity of 40 million bottles annually.

Financial details of the agreement were not disclosed.

OSE Immunotherapeutics wide-acting COVID-19 vaccine to enter trials
OSE Immunotherapeutics will shortly begin a phase I clinical trial evaluating CoVepiT, its COVID-19 vaccine candidate on 48 healthy volunteers in Belgium.
Clinical pipeline promises effective 2nd-generation COVID-19 vaccines
Despite the small number of COVID-19 vaccines that have been granted emergency use authorizations by the U.S. Food and Drug Administration to date, many...
EPO grants OSE patent for its anti-IL-7R antagonist
OSE Immunotherapeutics has been granted a patent by the European Patent Office (EPO) for the intellectual property rights for its anti-interleukin-7 receptor...
OSE, MabSilico collaborate on AI-driven mAb development
OSE Immunotherapeutics and MabSilico have partnered to use artificial intelligence (AI)-based software for therapeutic monoclonal antibody (mAb) drug...

Copyright © 2021 scienceboard.net

CPhI North America
August 10-12
Philadelphia, Pennsylvania United States
Bioprocessing Summit
August 16-19
Boston, Massachusetts United States
6th Annual CAR-TCR Summit
August 30 - September 2
European Congress of Immunology (ECI) 2021
September 1-4
Belgrade Serbia
Medical Affairs Strategic Summit (MASS)
September 13-15
New Brunswick, New Jersey United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter